A randomized, open-label study to determine the relative bioavailability of inhaled indacaterol maleate (with and without oral activated charcoal) delivered via the EPIC Test Fixture in healthy adult subjects.

Trial Profile

A randomized, open-label study to determine the relative bioavailability of inhaled indacaterol maleate (with and without oral activated charcoal) delivered via the EPIC Test Fixture in healthy adult subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Indacaterol (Primary) ; Charcoal
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Pharmacogenomic; Pharmacokinetics
  • Sponsors Novartis
  • Most Recent Events

    • 06 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top